miR-93/miR-106b/miR-375-CIC-CRABP1: A novel regulatory axis in prostate cancer progression

Oncotarget

Volumn 6, Issue 27, 2015, Pages 23533-23547

  Choi, Nahyun ^a   Park, Jongmin ^a   Lee, Jeon Soo ^a   Yoe, Jeehyun ^a   Park, Guk Yeol ^a   Kim, Eunjeong ^a   Jeon, Hyeongrin ^a   Cho, Yong Mee ^b   Roh, Tae Young ^a   Lee, Yoontae ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Capicua; CRABP1; ETV5; MicroRNA; Prostate cancer

Indexed keywords

BINDING PROTEIN; CAPICUA; CELLULAR RETINOIC ACID BINDING PROTEIN 1; HIGH MOBILITY GROUP PROTEIN; MICRORNA; MICRORNA 106B; MICRORNA 375; MICRORNA 93; UNCLASSIFIED DRUG; CIC PROTEIN, HUMAN; DNA BINDING PROTEIN; ETV5 PROTEIN, HUMAN; MIRN106 MICRORNA, HUMAN; MIRN375 MICRORNA, HUMAN; MIRN93 MICRORNA, HUMAN; REPRESSOR PROTEIN; RETINOIC ACID BINDING PROTEIN I, CELLULAR; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CRABP1 GENE; DOWN REGULATION; ETV5 GENE; GENE; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PC 3 CELL LINE; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR INVASION; UPREGULATION; APOPTOSIS; CARCINOMA; DISEASE COURSE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

EID: 84943409869     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4372     Document Type: Article

References (38)

1. Jiménez G, Guichet A, Ephrussi A, Casanova J. Relief of gene repression by torso RTK signaling:role of capicua in Drosophila terminal and dorsoventral patterning. Genes Dev 2000;14:224-231.
2. Jiménez G, Shvartsman SY, Paroush Z. The Capicua repressor-a general sensor of RTK signaling in development and disease. J Cell Sci 2012;125:1383-1391.
3. Zhu LJ, Christensen RG, Kazemian M, Hull CJ, Enuameh MS, Basciotta MD, Brasefield JA, Zhu C, Asriyan Y, Lapointe DS, Sinha S, Wolfe SA, Brodsky MH. FlyFactorSurvey:a database of Drosophila transcription factor binding specificities determined using the bacterial one-hybrid system. Nucleic Acids Res 2011;39:D111-117.
4. Shin D-H, Hong J-W. Capicua is involved in Dorsalmediated repression of zerknüllt expression in Drosophila embryo. BMB Rep 2014;47:518-523.
5. Lam YC, Bowman AB, Jafar-Nejad P, Lim J, Richman R, Fryer JD, Hyun ED, Duvick LA, Orr HT, Botas J, Zoghbi HY. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 2006; 127:1335-1347.
6. Fryer JD, Yu P, Kang H, Mandel-Brehm C, Carter AN, Crespo-Barreto J, Gao Y, Flora A, Shaw C, Orr HT, Zoghbi HY. Exercise and genetic rescue of SCA1 via the transcriptional repressor Capicua. Science 2011;334:690-693.
7. Lee Y, Fryer JD, Kang H, Crespo-Barreto J, Bowman AB, Gao Y, Kahle JJ, Hong JS, Kheradmand F, Orr HT, Finegold MJ, Zoghbi HY. ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization. Dev Cell 2011;21:746-757.
8. Kim E, Park S, Choi N, Lee J, Yoe J, Kim S, Jung HY, Kim KT, Kang H, Fryer JD, Zoghbi HY, Hwang D, Lee Y. Deficiency of Capicua disrupts bile acid homeostasis. Sci Rep 2015;5:8272.
9. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268-274.
10. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J, Moorhead M, Chaudhuri S, Tomsho LP, et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010;466:869-873.
11. Alentorn A, Sanson M, Idbaih A. Oligodendrogliomas: new insights from the genetics and perspectives. Curr Opin Oncol 2012;24:687-693.
12. Kawamura-Saito M, Yamazaki Y, Kaneko K, Kawaguchi N, Kanda H, Mukai H, Gotoh T, Motoi T, Fukayama M, Aburatani H, Takizawa T, Nakamura T. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewinglike sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet 2006;15:2125-2137.
13. Kurpios NA, Sabolic NA, Shepherd TG, Fidalgo GM, Hassell JA. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. J Mammary Gland Biol Neoplasia 2003;8:177-190.
14. Dissanayake K, Toth R, Blakey J, Olsson O, Campbell DG, Prescott AR, MacKintosh C. ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúa. Biochem J 2011;433:515-525.
15. Clark JP, Cooper CS. ETS gene fusions in prostate cancer. Nat Rev Urol 2009;6:429-439.
16. Russell PJ, Kingsley EA. Human prostate cancer cell lines. Methods Mol Med 2003;81:21-39.
17. Oh S, Shin S, Janknecht R. ETV1, 4 and 5:an oncogenic subfamily of ETS transcription factors. Biochim Biophys Acta 2012;1826:1-12.
18. Kainov Y, Favorskaya I, Delektorskaya V, Chemeris G, Komelkov A, Zhuravskaya A, Trukhanova L, Zueva E, Tavitian B, Dyakova N, Zborovskaya I, Tchevkina E. CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors. Cell Cycle 2014; 13:1530-1539.
19. Sirotnak FM, She Y, Khokhar NZ, Hayes P, Gerald W, Scher HI. Microarray analysis of prostate cancer progression to reduced androgen dependence:studies in unique models contrasts early and late molecular events. Mol Carcinog 2004;41:150-163.
20. Crespo-Barreto J, Fryer JD, Shaw CA, Orr HT, Zoghbi HY. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis. PLoS Genet 2010;6:e1001021.
21. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, Yfantis HG, Stephens RM, Croce CM. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008;68:6162-6170.
22. Ozen M, Creighton CJ, Ozdemir M, Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 2008;27:1788-1793.
23. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TLJ, Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res 2007;67:6130-6135.
24. Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, Senzer N, Eklund AC, Han J, Nemunaitis J. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 2009;16:206-216.
25. Schaefer A, Jung M, Mollenkopf H-J, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 2010; 126:1166-1176.
26. Wach S, Nolte E, Szczyrba J, Stöhr R, Hartmann A, Ørntoft T, Dyrskjøt L, Eltze E, Wieland W, Keck B, Ekici AB, Grässer F, Wullich B. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening. Int J Cancer 2012;130:611-621.
27. Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F. The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res 2010;8:529-538.
28. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20.
29. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. Combinatorial microRNA target predictions. Nat Genet 2005;37:495-500.
30. Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals:determinants beyond seed pairing. Mol Cell 2007;27:91-105.
31. Shin C, Nam J-W, Farh KK-H, Chiang HR, Shkumatava A, Bartel DP. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 2010; 38:789-802.
32. Won JY, Nam E-C, Yoo SJ, Kwon HJ, Um SJ, Han HS, Kim SH, Byun Y, Kim SY. The effect of cellular retinoic acid binding protein-I expression on the CYP26-mediated catabolism of all-trans retinoic acid and cell proliferation in head and neck squamous cell carcinoma. Metab Clin Exp 2004;53:1007-1012.
33. Dong D, Ruuska SE, Levinthal DJ, Noy N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J Biol Chem 1999;274:23695-23698.
34. Wegiel B, Bjartell A, Tuomela J, Dizeyi N, Tinzl M, Helczynski L, Nilsson E, Otterbein LE, Härkönen P, Persson JL. Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis. J Natl Cancer Inst 2008;100:1022-1036.
35. Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, Sooriakumaran P, Robinson BD, Leung R, Schinzel AC, Mills I, Ross-Adams H, Neal DE, et al. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc Natl Acad Sci USA 2012;109:11252-11257.
36. Hart M, Nolte E, Wach S, Szczyrba J, Taubert H, Rau TT, Hartmann A, Grässer FA, Wullich B. Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing. Mol Cancer Res 2014; 12:250-263.
37. Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, Zoghbi HY. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 2008;11:1137-1139.
38. Choe MK, Hong C-P, Park J, Seo SH, Roh T-Y. Functional elements demarcated by histone modifications in breast cancer cells. Biochem Biophys Res Commun 2012; 418:475-482.